Our latest report highlights emerging trends for AI in the IP industry, including how stakeholders are adopting these new tools. Download the report here.
By bringing clarity to the complex, we give our customers the confidence to make critical decisions, navigate roadblocks and achieve their potential.
Our new report offers steps life science companies can take to de-risk their clinical trials and improve their odds of market approval. Read more today.
Big data from the Web of Science helps answer questions about collaboration, both within and beyond the world of research.
Big data from the Web of Science helps answer questions about collaboration, both within and beyond the world of research.
This is an adapted excerpt from David Pendlebury’s contributed chapter in the recently published Handbook Bibliometrics. His chapter explores how Eugene Garfield and his Institute for Scientific Information (ISI)™ helped revolutionize information retrieval in the second half of the twentieth century by introducing the concept of citation indexing for scientific literature. The history, sociology […]
We discuss representation in innovation and inventorship, looking at diversity and inclusion from an intellectual property perspective. Read more.
Drug pricing, R&D productivity are in spotlight as ‘megamerger party’ ends
Patents are a fundamental tool to generate return on investment for a business. They can be used defensively to prevent others from copying, manufacturing, selling or importing your invention without your permission. Or they can be used strategically in licensing or M&A negotiations as a bargaining tool. But, however they are used, they have no […]